arrow
J

John Lenehan

london health sciences research institute
H指数:12
被引数:990

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Metabolic determinants of cancer immunotherapy outcomes identified by plasma profiling

通过血浆谱分析确定的癌症免疫治疗结果的代谢决定因素

2026-06-250
OAAI
Health care impact of comprehensive genomic profiling of solid tumors in patient management using POWER (Precision Oncology at Western University)
2026-02-050
PRE
Phase II trial of fecal microbiota transplantation in combination with ipilimumab and nivolumab in patients with advanced cutaneous melanoma (FMT-LUMINate trial)
2024-04-050
PRE
Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial (vol 29, pg 2121, 2023 )

晚期黑色素瘤的粪便微生物群移植加anti-PD-1免疫疗法: I期试验 (第29卷,2121页,2023页)

2023-11-031
OA
Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial

晚期黑色素瘤的粪便菌群移植加anti-PD-1免疫治疗: I期试验

2023-07-06118
PRE
Letrozole concentration is associated with CYP2A6 variation but not with arthralgia in patients with breast cancer
2018-08-0916
PREAI